A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL

Clinical trial NCT03349333 · COMPLETED

Trial details

NCT number: NCT03349333
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Refractory Peripheral T-Cell Lymphoma Relapsed T-Cell Lymphoma

Start date: 2015-09-10
Primary completion: 2017-07-21
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.